BridgeBio Pharma (BBIO) FCF Margin (QoQ) (2020 - 2026)
BridgeBio Pharma (BBIO) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,416.00 |
| Dec 31, 2025 | 5,349.00 |
| Sep 30, 2025 | -1,782.00 |
| Jun 30, 2025 | 9,785.00 |
| Mar 31, 2025 | 315,000.00 |
| Dec 31, 2024 | 329,594.00 |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | 357,885.00 |
| Mar 31, 2024 | 704,336.00 |
| Dec 31, 2023 | -360,385.00 |
| Sep 30, 2023 | 338,981.00 |
| Jun 30, 2023 | 97,074.00 |
| Mar 31, 2023 | -266,353.00 |
| Dec 31, 2022 | 3.38 Mn |
| Sep 30, 2022 | -3.90 Mn |
| Jun 30, 2022 | 948,216.00 |
| Mar 31, 2022 | -807,994.00 |
| Dec 31, 2021 | 366,238.00 |
| Sep 30, 2021 | -493,498.00 |
| Jun 30, 2021 | 3.28 Mn |